It should not be used as a substitute for professional medical judgment, diagnosis, or treatment
Lancet Diabetes Endocrinol 2(10):801809 Li K, Zou J, Ye Z, Di J, Han X, Zhang H et al (2016) Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis
in laboratory research it has been characterized as a selective agonist of the growth-hormone secretagogue receptor (GHS-R1a) that triggers growth-hormone release with comparatively low reported activity at corticotroph and lactotroph pathways in animal models
GLP-1 receptor agonists in heart failure: how far to expand use
While the price discounts make coverage more affordable, state Medicaid budgets are already under pressure, and it seems unlikely that many will choose to add this coverage now
A 14 mg semaglutide pill form was associated with more weight loss than the injectable GLP-1s lixisenatide (which is no longer on the market in the United States) and exenatide